The diagnosis of an infectious disease, is usually accomplished by cultivating the infecting agent in a laboratory animal or an artificial culture medium (1) . However, in many situations this procedure takes too long to provide useful information to the physician caring for a patient with suspected infectious disease. As long as 14 days is required to detect and identify many viral agents (2, 3) . Similarly, proper diagnosis of fungal infection, an important problem in immunocompromised. patients such as those receiving cancer chemotherapy, can be lengthy (4). Although bacterial agents can be cultivated more quickly, the 48 h required to identify most bacterial pathogens is often too long to wait before instituting appropriate antibiotic chemotherapy (3) . However, many enzymes are elaborated by a wide range of microbial organisms but are not produced by human cells (Table 1 ). For example, many bacterial organisms have enzymes involved in the synthesis of the rigid cell wall, a structure which does not occur in mammalian cells (37, 38) . In the case of fungal organisms, there are also a number of enzymes involved in the breakdown of polysaccharides and metabolism of purines; these enzymes appear unique to this group of organisms (39). Moreover, several enzymes associated with nucleic acid synthesis occur only in viruses (40).
The existence of enzymes in a wide range of microorganisms but not in mammalian cells raises the possibility that detection of these enzymes in human body fluids might be a specific indicator of microbial infection. In addition, if enzymes are selected that have favorable kinetics, very low amounts of enzyme might be detected, especially if high-energy substrates are used (23, 41, 42) . Also, because no antigen-antibody or solid-phase reactions need be utilized, the detection level of the microbial enzymes would not be dependent on antigenantibody kinetics or the binding properties of solid-phase surfaces (28,43).
Specific Methods of Detection with EIA

Bacteria
In the case of bacteria, one enzyme which has proven useful for the measurement of bacterial infection is -lactamase (EC 3.5.2.6). fl-Lactamases are present in most bacterial species although the amount present can vary greatly and is dependent not only on the bacterial species but also on environmental conditions (44,45). The ubiquitousness of fl-lactamase is probably due to its involvement in cross-linking the components of the bacterial cell wall (46, 47). In addition, the widespread therapeutic use of penicillin and penicillin derivatives has led to the genetic selection of 3-lactamase-producing organisms, especially in the case of bacterial species such as Staphylococci and Gonococci. Although fi-lactamases produced by different species of microorganisms vary in their molecular structure, antigenicity, and substrate specificity, all are capable of hydrolyzing penicillin to the corresponding penicilloic acid (Figure 1 ). In addition, most possess specific activities in excess of 100 000 molecules/mm under physiologic conditions (47-49). Thus, a system capable of measuring the conversion of penicillin to penicilloic acid might be capable of measuring small amounts of fi-lactamase and, hence, small quantities of microorganisms.
The fact that -lactamases do not appear to occur in mammalian cells suggests that detection of /3-lactamase in human body fluid might be an indicator of (Table 4) .
Of particular interest were the results with the organism
Haemophilus in! luenzae
(53). These organisms, which are common causesofserious infections inthefirst two years of life, are of concern to physicians because many of them produce so much /3-lactamase that /3-lactam antibiotics such as penicillin and ampicillin cannot be utilized. This necessitates theuse of more toxic antibiotics such as chioramphenicol
(54).
Testing of specimens containing these organisms revealed that some had very high activities of /3-lactamase (> 200 units/L); others were in the range of about 1 zunitfL (Table 5 ). The specimens containing the higher activities yielded penicillin-resistant organisms, whereas those having lower activities yieldedorganismssensitive to ampicillin. Itisthus possible that /3-lactamase determinations could be used not only to diagnose the presence of a microorganism in a body fluid but also to estimate the potential usefulness of chemotherapy with a /3-lactam antibiotic.
Because /3-lactamase produced by different species of microorganisms has different substrate specificities, the information obtained from /3-lactamase determinations may possibly be augmented by testing different /3-lactamase sub- To determine the amount of conversion specifically due to /3-lactamase, subtract the conversion measured in the reaction mixture containing the /3-lactamase inhibitor from that in the mixture not containing the inhibitor. A specimen is considered to contain f3-Iactamase activity if it yields a specific enzymic conversion 2 standard deviations greater than the mean conversion of the negative control specimen. The negative control specimens are of the same body fluid as the clinical specimens tested. 
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We In addition, these enzymes have sufficiently high turnover rates to allow for the measurement of small amounts of enzymes, especially if fluorescent substrates are used (62, 63). Efficient fluorescent substrates for these enzymes can be generated by the linkage of 4-methylumbelliferone to the glycoside (21) . These substrates display minimal fluorescence unless they are hydrolyzed by the specific glycosidase to yield the free 4-methylumbelliferone
(64).
Unfortunately, the usefulness of the glycosidases as specific markers for bacterial infection is limited by the fact that many of these enzymes occur in mammalian cells. However, bacterial glycosidases can be distinguished somewhat from mammalian glycosidases by being active at pH 7.0 whereas the mammalian enzymes are most active at pH 5.0 and have less activity at neutral pH (65, 66) . In addition, thebacterial origin of glycosidases can be determined by the fact that their generation is inhibited by the addition of antibiotics to the reaction milieu. Also, glycosidases in cell wall structures might be specifically released by treating a specimen with enzymes like lysozyme, to hydrolyze linkages found only in prokaryotic cell walls. Preliminary experiments indicate that the measurement of bacterial glycosidases such as neuraminidase and Nacetylglucosaminidase are useful for the detection of streptococcal infection in experimental animals and, in some cases, humans. More extensive evaluation of the bacterial glycos. strates such as carbenicillin, ampicillin, phenoxymethylpenicillin, and various cephalosporins as well as penicillin G. Unfortunately, 14C-labeled compounds are not available for these different substrates. The development of such compounds or the development of a sensitive nonradiometric system for the measurement of conversion of these drugs to their corresponding penicmlloic acids would markedly augment the usefulness of the /3-lactamase measurement system. One limitation of the use of f3-lactamase to diagnose bacterial infection is that some microorganisms, notably,
Streptococcus pneumoniae
and Neisseria meningitidis, either do not elaborate /3-lactamase or produce the enzyme at activities below the limits of detectability. Having additional bacterial enzymes available would thus be useful. One potentially useful microbial enzyme is penicillin acylase (no BC no. assigned), which converts penicillin compounds into the corresponding 6-aminopenicilloic acids. This enzyme is elaborated by a wide range of microorganisms, including most species of Streptococci and Neisseria (55, 56) . On the other hand, mammalian acylases have little activity for penicillin molecules. Thus, the detection of penicillin acylase in a body fluid might indicate microbial infection (57).
One problem withthefeasibility ofusingpenicillin acylase asa marker forbacterial infection isthelackofsensitivity and specificity ofavailable assaysforthe measurement ofthese enzymes (57, 58). We thus devised a radiometric method, similar to that for 13-lactamase, based on the fact that ['4C]-penicilloic acid,with two negative charges, will bind to a positively charged ion-exchange resin more strongly than will the monobasic 6-aminopenicilloic acid product of penicillin acylase activity. This method is sufficiently sensitive to detect 0.1 ng of enzyme obtained from E. coli (Figure 2 ) and can be used with a wide range of microorganisms in broth cultures. idase detection systems are currently being undertaken to determinethesensitivity and specificity of such systems for the detection ofmicrobial contamination.
Fungai Organisms
Fungal organisms are important causes of infections in immunocompromised patients and those undergoing cancer chemotherapy (4). Fungi are phylogenetically related to bacteria and contain a number of metabolic pathways that also occur in a large number of bacteria. However, the fact that the medically important fungi such as AspergiUus and Mucormycosis species and yeasts such as Candida and Histoplasma species are notsensitive to antibiotics commonly used to treat bacteria necessitates distinguishing these organisms from pathogenic bacteria (67) . The specific diagnosis of fungal infections is thus required to justify the institution of treatment with amphotericin B, an effective antifungal agent, but one with toxicity too great to allow for its indiscriminate use of in the absence of a specific diagnosis (68) . Several antigenic assays have been developed for the rapid detection of fungal infections, but many are insufficiently sensitive or specific for routine use (69) .
Although bacterial and fungal microorganisms share a number of enzymes such as the glycosidases and penicillin acylases described above (60, 70) , some enzymes appear to be unique to fungi. Fungi can grow in media containing complex carbohydrates such as inulin as the sole carbon source (61); consequently, inulinase (EC 3.2.1.7) and the pentosanases are found largely in fungal microorganisms. In addition, the fungal organisms tend to catalyze oxidative reactions such as the oxidation of glucose to gluconic acid (71) . The detection of such oxidative enzymes as glucose oxidase (EC 1.1.3.4) might thus be good markers for fungal contamination. Moreover, the fungal cell wall tends to contain a higher concentration of chitin, a homopolymer of N-acetylglucosamine, than the N-acetylglucosamine-muraminic acid linkage found in most bacteria (72, 73) . Thus, the presence of chitinase or chitin synthetase, enzymes that all fungi must possess to modify their cell walls, might be efficient markers for fungal infection.
Unfortunately, currently available detection systems for the above enzymes are either insufficiently sensitive or insufficiently specific to detect the wide range of fungal microorganisms involved in human disease (74, 75) . For example, the amounts of inulinase and pentosanase produced by pathogenic fungi in human body fluids are too small to be detected by standard available systems. As for the use of chitinase (EC 3.2.1.14) as a marker for fungal infections, a sensitive method for the measurement of chitinase activity has been developed, involving the measurement of [3H]Nacetylgiucosamine liberated from [3H]chitin (76) . However, the usefulness of this system is complicated by the fact that lysozyme (EC 3.2.1.17), common in human body fluids, is also capable of breaking down the chitin to N-acetylglucosamine (77) , so that it is difficult to distinguish chitinase activity from lysozyme activity. A sensitive method for the specific detection of chitinase activity might be a useful tool for the rapid detection of fungal contamination.
One pathway showing promise for the detection of fungal infections is that of the purine deaminases. These enzymes, which are widely distributed throughout the fungi but absent from most bacteria and all mammalian cells, catalyze the deamination of adenine and other purines to deaminated derivatives (78, 79) . The specificity of this enzyme pathway is the basis for the activity of the anti -fungal drug, 5-fluorocytosine (80) . This drug is converted to 5-fluorouracil, an inhibitor of nucleic acid synthesis, by fungal microorganisms but not by mammalian cells (81) . We have developed an enzymic radioisotopic assay, similar to that for /3-lactamase, for measuring purine deaminase. Tritium-labeled adenine is incubated with the specimen; if purine deaminase is present, it will convert the [3H]adenine to [3H]hypoxanthine.
The adenine can be separated from hypoxanthine by ion-exchange chromatography with a negatively charged gel such as SPSepharose (Figure 3) . Unfortunately, there is no specific enzymic inhibitor to provide for a simple control reaction. However, the purine deaminases are highly sensitive to mercuric compounds (82) . Thus, enzyme-mediated deamination can be distinguished from non-enzymic breakdown by incubation with such compounds. The other pathways of adenine metabolism, such as the conversion of adenine to adenosine and adenosinemonophosphate, must also be blocked, which can be done by incubating the specimen with excess adenosine (83) . We have utilized this enzymic radioisotopic assay to measure adenine deaminase (EC 3.5.4.17) in small concentrations of fungal organisms. This assay has also been useful in the early detection of some human infections due to Aspergillus fumigatus and Candida tropicalis. In one case we were able to document the response to the antifungal drug amphotericin B by means of decreasing concentrations of adenine deaminase in the patient's blood. This and other fungal enzymic systems should undergo further evaluation to determine their specificity and sensitivity as markers for fungal infection.
Viral Infections
Viruses require a number of enzymes to accomplish a complete cycle of infection and replication. Some of these enzymes are unique to viral metabolism and do not occur in uninfected cells or other microorganisms (84) . Thus, the measurement of these enzymes in an infected cell or in a body fluid might be indicative of infection with these organisms (40). For example, all RNA viruses must possess either a RNA-dependent RNA polymerase or an RNA-dependent DNA polymerase to replicate (84) (85) (86) (87) . Because mammalian RNA is not generally capable of autonomous division, these enzymes are specific forviral organisms. The RNA-dependent DNA polymerases, also known as reverse transcriptases, are of particular interest in the study of tumors, these enzymes being present in a wide range of RNA tumor viruses (84, 85) . Currently, the usefulness of these enzymes as markers for viral infections is limited by the tediousness and relative insensitivity of the detection procedures. The development of more efficient means of detection might lead to sensitive assay systems based on the detection of viral-specific nucleic acid polymerases.
There are also a number of enzymes of DNA viruses that appear to be specific for viral metabolism, including the DNA endonuclease of adenoviruses and iridoviruses as well as the DNA exonuclease of pox virus (40). These enzymes have not as yet been used as tools for rapid diagnosis. However, several investigators have shown that cells infected with herpes viruses contain large amounts of detectable thymidine kinase (88) . This enzyme can be distinguished from mammalian thymidine kinase (EC 2.7.1.21) by a differing substrate specificity. For example, the viral thymidine kinase has a high rate of reactivity with deoxycytidine and acycloguanine, whereas the mammalian enzyme has little affinity for these molecules (89, 90) . The differential activity of acycloguanine, also known as acyclovir, has led to the use of this compound as an antiviral drug especially suited for the treatment of herpessimplexvirusinfection (91). Preliminary studies in our laboratory indicate thatthe measurement ofdeoxycytidine kinase(EC 2.7.1.74) activity is a sensitive marker for herpes simplex virus infection under certain clinical circumstances. Addition investigations of the use of this drug as a marker for infection with members of the herpes virus group should be undertaken.
An additional viral enzyme that has proven useful as a marker for acute infection is neuraminidase (EC 3.2.1.18). This enzyme, which catalyzes the hydrolysis of sialic acid from a number of sialic acid-containing glycosidases, is present on all pathogenic influenza viruses and, to a lesser extent, parainfluenza viruses (92, 93) . Because the enzyme is present on the exterior of the virus, its measurement does not require disruption of intact virions (94). One limitation of neuraminidase as a marker for viral infection is that neuraminidases can also occur in bacteria and mammalian cells (95). However, viral neuraminidase can be distinguished from bacterial and mammalian neuraminidase by the fact that divalent cations such as calcium and magnesium are required for its action, and it is thus inhibited by chelating agents such EDTA (96). Measurement of neuraminidase activity has been facilitated by the availability of a sensitive fluorescent substrate, prepared by linking sialic acid with 4-methylumbelliferone.
The intact glycoside has little fluorescence; however, upon the action of neuraminidase, the highly fluorescent 4-methylumbelliferone is liberated (97). We have used this system to detect as little as one infectious dose of some strains of influenza virus (Figure 4 ). In addition, we found that the pres- ence of neuraminidase activity inhibited by EDTA was a reliable marker for influenza virus infection in human volunteers experimentally infected with influenza A/Alaska (98) ( Figure   5 ).The influenzaviruscould be identified as to neuraminidase antigenic type by a solid-phase immunoenzymic assay. We bound the virus to a solid phase by means of monoclonal antibody directedagainstthe neuraminidase, then measured the neuraminidase activity bound to the solidphase with use of the fluorescent substrate (98). We are currently evaluating this system on specimens from naturally occurring influenza virus infection. We are also attempting to identify additional viral-specific enzymes that might be used for rapid detection of viral infections in humans and animals.
Enzymes can be measured in small quantities by means of relatively simple techniques. The fact that some enzymes are peculiar to microorganisms offers the possibility that the measurement of these enzymes in blood or other body fluids can provide a rapid, sensitive means for the detection of microorganisms and the diagnosis of infectious diseases. The development of such systems would markedly improve the medical care of patients with infectious diseases. I greatly appreciate the secretarial assistance of Patricia O'Neill.
